CB
MACK

Commerce Bank’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Commerce Bank’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5,465
Closed -$273K – 843
2016
Q3 		$273K Sell
5,465
-7,245
-57% -$301K ﹤0.01% 678
2016
Q2 		$539K Buy
+12,710
New +$692K 0.01% 479

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Commerce Bank's MACK Position: Q4 2016 in Review

Commerce Bank sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q4 2016, closing a stake of 5,465 shares — an estimated $273K sold.

Commerce Bank first reported a position in MACK in Q2 2016 and held it in 2 quarters. The position peaked at $539K in Q2 2016. 136 funds tracked by Wall St. Rank hold MACK as of Q4 2016.

  • Commerce Bank reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Commerce Bank sold 5,465 Merrimack Pharmaceuticals, Inc. shares in Q4 2016, an estimated $273K.
  • Commerce Bank first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2016 and held it in 2 quarters.
  • Commerce Bank's Merrimack Pharmaceuticals, Inc. position peaked at $539K in Q2 2016.
  • 136 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2016.

Based on Commerce Bank's 13F filing for Q4 2016, filed 8 Feb 2017.